|
Early Detection of Prostate Cancer
The American Urological Association (AUA) and the AUA Foundation believe that early detection of and risk assessment for prostate cancer should be offered to asymptomatic men 40 years of age or older who have a life expectancy of at least 10 years. Men who wish to be screened should have both a prostate-specific antigen (PSA) test and a digital rectal exam (DRE). The decision to proceed to prostate biopsy should be based not only on PSA and DRE results, but should take into account multiple factors including free and total PSA, patient age, PSA velocity, PSA density, family history, ethnicity, prior biopsy history and comorbidities. The AUA strongly supports informed consent before screening is undertaken and the option of active surveillance, in lieu of immediate treatment, for certain men found to have prostate cancer.
For more information about prostate cancer detection, view the 2009 AUA Best Practice Statement on Prostate-Specific Antigen.
Board of Directors, January 1992
Board of Directors, May 1992 (Reaffirmed)
Board of Directors, August 1993 (Revised)
Board of Directors, January 1994 (Revised)
Board of Directors, January 1995 (Revised)
Board of Directors, September 1997 (Revised)
Board of Directors, March 2001 (Revised)
Board of Directors, May 2006 (Revised)
Board of Directors, October 2008 (Revised)
Board of Directors, April 2009 (Revised)
|
